Glucagon-like peptide 1 and the brain: Central actions-central sources?

Autonomic Neuroscience: Basic and Clinical

Volumn 161, Issue 1-2, 2011, Pages 14-19

  Trapp, Stefan ^a   Hisadome, Kazunari ^a,b  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

^b SAGA UNIVERSITY   (Japan)

Author keywords

Food intake; Glucagon like peptide 1; Glucose homeostasis; Nucleus of the solitary tract

Indexed keywords

GLUCAGON LIKE PEPTIDE 1; GLUCAGON LIKE PEPTIDE 1 RECEPTOR;

ANOREXIA; ARTICLE; BRAIN; BRAIN STEM; HORMONE RELEASE; HYPOTHALAMUS; NAUSEA; NERVE CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION;

ANIMALS; BRAIN; EATING; GLUCAGON-LIKE PEPTIDE 1; MICE; MICE, TRANSGENIC; RECEPTORS, GLUCAGON; SIGNAL TRANSDUCTION;

EID: 79953758204     PISSN: 15660702     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.autneu.2010.09.008     Document Type: Article

References (71)

1. Abbott C.R., Monteiro M., Small C.J., Sajedi A., Smith K.L., Parkinson J.R., Ghatei M.A., Bloom S.R. The inhibitory effects of peripheral administration of peptide YY(3-36) and glucagon-like peptide-1 on food intake are attenuated by ablation of the vagal-brainstem-hypothalamic pathway. Brain Res. 2005, 1044:127-131.
2. Ashcroft F.M., Rorsman P. Electrophysiology of the pancreatic beta-cell. Prog. Biophys. Mol. Biol. 1989, 54:87-143.
3. Balfour R.H., Trapp S. Ionic currents underlying the response of rat dorsal vagal neurones to hypoglycaemia and chemical anoxia. J. Physiol. 2007, 579:691-702.
4. Balfour R.H., Hansen A.M., Trapp S. Neuronal responses to transient hypoglycaemia in the dorsal vagal complex of the rat brainstem. J. Physiol. 2006, 570:469-484.
5. Bucinskaite V., Tolessa T., Pedersen J., Rydqvist B., Zerihun L., Holst J.J., Hellstrom P.M. Receptor-mediated activation of gastric vagal afferents by glucagon-like peptide-1 in the rat. Neurogastroenterol. Motil. 2009, 21:978-985.
6. Burdakov D., Jensen L.T., Alexopoulos H., Williams R.H., Fearon I.M., O'Kelly I., Gerasimenko O., Fugger L., Verkhratsky A. Tandem-pore K+ channels mediate inhibition of orexin neurons by glucose. Neuron 2006, 50:711-722.
7. Cabou C., Campistron G., Marsollier N., Leloup C., Cruciani-Guglielmacci C., Penicaud L., Drucker D.J., Magnan C., Burcelin R. Brain glucagon-like peptide-1 regulates arterial blood flow, heart rate, and insulin sensitivity. Diabetes 2008, 57:2577-2587.
8. Cani P.D., Knauf C., Iglesias M.A., Drucker D.J., Delzenne N.M., Burcelin R. Improvement of glucose tolerance and hepatic insulin sensitivity by oligofructose requires a functional glucagon-like peptide 1 receptor. Diabetes 2006, 55:1484-1490.
9. Chelikani P.K., Haver A.C., Reidelberger R.D. Intravenous infusion of glucagon-like peptide-1 potently inhibits food intake, sham feeding, and gastric emptying in rats. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2005, 288:R1695-R1706.
10. Chelikani P.K., Haver A.C., Reidelberger R.D. Ghrelin attenuates the inhibitory effects of glucagon-like peptide-1 and peptide YY(3-36) on food intake and gastric emptying in rats. Diabetes 2006, 55:3038-3046.
11. Drucker D.J. The biology of incretin hormones. Cell Metab. 2006, 3:153-165.
12. Drucker D.J., Nauck M.A. The incretin system: glucagon-like peptide-1 receptor agonists and dipeptidyl peptidase-4 inhibitors in type 2 diabetes. Lancet 2006, 368:1696-1705.
13. Elias C.F., Kelly J.F., Lee C.E., Ahima R.S., Drucker D.J., Saper C.B., Elmquist J.K. Chemical characterization of leptin-activated neurons in the rat brain. J. Comp. Neurol. 2000, 423:261-281.
14. Flint A., Raben A., Astrup A., Holst J.J. Glucagon-like peptide 1 promotes satiety and suppresses energy intake in humans. J. Clin. Invest. 1998, 101:515-520.
15. Franklin K.B.J., Paxinox G. The Mouse Brain in stereotaxic coordinates 2008, Academic Press, London. Third Edition.
16. Gaykema R.P., Daniels T.E., Shapiro N.J., Thacker G.C., Park S.M., Goehler L.E. Immune challenge and satiety-related activation of both distinct and overlapping neuronal populations in the brainstem indicate parallel pathways for viscerosensory signaling. Brain Res. 2009, 1294:61-79.
17. Goldstone A.P., Mercer J.G., Gunn I., Moar K.M., Edwards C.M., Rossi M., Howard J.K., Rasheed S., Turton M.D., Small C., Heath M.M., O'Shea D., Steere J., Meeran K., Ghatei M.A., Hoggard N., Bloom S.R. Leptin interacts with glucagon-like peptide-1 neurons to reduce food intake and body weight in rodents. FEBS Lett. 1997, 415:134-138.
18. Goldstone A.P., Morgan I., Mercer J.G., Morgan D.G., Moar K.M., Ghatei M.A., Bloom S.R. Effect of leptin on hypothalamic GLP-1 peptide and brain-stem pre-proglucagon mRNA. Biochem. Biophys. Res. Commun. 2000, 269:331-335.
19. Gutzwiller J.P., Drewe J., Goke B., Schmidt H., Rohrer B., Lareida J., Beglinger C. Glucagon-like peptide-1 promotes satiety and reduces food intake in patients with diabetes mellitus type 2. Am. J. Physiol. 1999, 276:R1541-R1544.
20. Gutzwiller J.P., Goke B., Drewe J., Hildebrand P., Ketterer S., Handschin D., Winterhalder R., Conen D., Beglinger C. Glucagon-like peptide-1: a potent regulator of food intake in humans. Gut 1999, 44:81-86.
21. Hayashi Y., Yamamoto M., Mizoguchi H., Watanabe C., Ito R., Yamamoto S., Sun X.Y., Murata Y. Mice deficient for glucagon gene-derived peptides display normoglycemia and hyperplasia of islet {alpha}-cells but not of intestinal L-cells. Mol. Endocrinol. 2009, 23:1990-1999.
22. Hayes M.R., Skibicka K.P., Grill H.J. Caudal brainstem processing is sufficient for behavioral, sympathetic, and parasympathetic responses driven by peripheral and hindbrain glucagon-like-peptide-1 receptor stimulation. Endocrinology 2008, 149:4059-4068.
23. Hayes M.R., Bradley L., Grill H.J. Endogenous hindbrain glucagon-like peptide-1 receptor activation contributes to the control of food intake by mediating gastric satiation signaling. Endocrinology 2009, 150:2654-2659.
24. Hisadome K., Reimann F., Gribble F.M., Trapp S. CCK-stimulation of GLP-1 neurons involves alpha2 adrenergic receptor activation. Proc. Physiol. Soc. 2010, 18:C16.
25. Hisadome K., Reimann F., Gribble F.M., Trapp S. Leptin directly depolarises preproglucagon neurons in the nucleus tractus solitarius. Diabetes 2010, 59:1890-1898.
26. Holmes G.M., Browning K.N., Tong M., Qualls-Creekmore E., Travagli R.A. Vagally mediated effects of glucagon-like peptide 1: in vitro and in vivo gastric actions. J. Physiol. 2009, 587:4749-4759.
27. Holst J.J. The physiology of glucagon-like peptide 1. Physiol. Rev. 2007, 87:1409-1439.
28. Holst J.J., Deacon C.F. Glucagon-like peptide-1 mediates the therapeutic actions of DPP-IV inhibitors. Diabetologia 2005, 48:612-615.
29. Huo L., Gamber K.M., Grill H.J., Bjorbaek C. Divergent leptin signaling in proglucagon neurons of the nucleus of the solitary tract in mice and rats. Endocrinology 2008, 149:492-497.
30. Jensen P.B., Blume N., Mikkelsen J.D., Larsen P.J., Jensen H.I., Holst J.J., Madsen O.D. Transplantable rat glucagonomas cause acute onset of severe anorexia and adipsia despite highly elevated NPY mRNA levels in the hypothalamic arcuate nucleus. J. Clin. Invest. 1998, 101:503-510.
31. Jin S.L., Han V.K., Simmons J.G., Towle A.C., Lauder J.M., Lund P.K. Distribution of glucagonlike peptide I (GLP-I), glucagon, and glicentin in the rat brain: an immunocytochemical study. J. Comp. Neurol. 1988, 271:519-532.
32. Kastin A.J., Akerstrom V., Pan W. Interactions of glucagon-like peptide-1 (GLP-1) with the blood-brain barrier. J. Mol. Neurosci. 2002, 18:7-14.
33. Kieffer T.J., McIntosh C.H., Pederson R.A. Degradation of glucose-dependent insulinotropic polypeptide and truncated glucagon-like peptide 1 in vitro and in vivo by dipeptidyl peptidase IV. Endocrinology 1995, 136:3585-3596.
34. Kinzig K.P., D'Alessio D.A., Seeley R.J. The diverse roles of specific GLP-1 receptors in the control of food intake and the response to visceral illness. J. Neurosci. 2002, 22:10470-10476.
35. Knauf C., Cani P.D., Perrin C., Iglesias M.A., Maury J.F., Bernard E., Benhamed F., Gremeaux T., Drucker D.J., Kahn C.R., Girard J., Tanti J.F., Delzenne N.M., Postic C., Burcelin R. Brain glucagon-like peptide-1 increases insulin secretion and muscle insulin resistance to favor hepatic glycogen storage. J. Clin. Invest. 2005, 115:3554-3563.
36. Knauf C., Cani P.D., Kim D.H., Iglesias M.A., Chabo C., Waget A., Colom A., Rastrelli S., Delzenne N.M., Drucker D.J., Seeley R.J., Burcelin R. Role of central nervous system glucagon-like peptide-1 receptors in enteric glucose sensing. Diabetes 2008, 57:2603-2612.
37. Lachey J.L., D'Alessio D.A., Rinaman L., Elmquist J.K., Drucker D.J., Seeley R.J. The role of central glucagon-like peptide-1 in mediating the effects of visceral illness: differential effects in rats and mice. Endocrinology 2005, 146:458-462.
38. Larsen P.J., Holst J.J. Glucagon-related peptide 1 (GLP-1): hormone and neurotransmitter. Regul. Pept. 2005, 128:97-107.
39. Larsen P.J., Tang-Christensen M., Holst J.J., Orskov C. Distribution of glucagon-like peptide-1 and other preproglucagon-derived peptides in the rat hypothalamus and brainstem. Neuroscience 1997, 77:257-270.
40. Merchenthaler I., Lane M., Shughrue P. Distribution of pre-pro-glucagon and glucagon-like peptide-1 receptor messenger RNAs in the rat central nervous system. J. Comp. Neurol. 1999, 403:261-280.
41. Mizuno Y., Oomura Y. Glucose responding neurons in the nucleus tractus solitarius of the rat: in vitro study. Brain Res. 1984, 307:109-116.
42. Nishizawa M., Nakabayashi H., Kawai K., Ito T., Kawakami S., Nakagawa A., Niijima A., Uchida K. The hepatic vagal reception of intraportal GLP-1 is via receptor different from the pancreatic GLP-1 receptor. J. Auton. Nerv. Syst. 2000, 80:14-21.
43. Oomura Y., Ono T., Ooyama H., Wayner M.J. Glucose and osmosensitive neurones of the rat hypothalamus. Nature 1969, 222:282-284.
44. Orskov C., Poulsen S.S., Moller M., Holst J.J. Glucagon-like peptide I receptors in the subfornical organ and the area postrema are accessible to circulating glucagon-like peptide I. Diabetes 1996, 45:832-835.
45. Reimann F., Habib A.M., Tolhurst G., Parker H.E., Rogers G.J., Gribble F.M. Glucose sensing in L cells: a primary cell study. Cell Metab. 2008, 8:532-539.
46. Rinaman L. A functional role for central glucagon-like peptide-1 receptors in lithium chloride-induced anorexia. Am. J. Physiol. 1999, 277:R1537-R1540.
47. Rinaman L. Interoceptive stress activates glucagon-like peptide-1 neurons that project to the hypothalamus. Am. J. Physiol. 1999, 277:R582-R590.
48. Ritter R.C., Slusser P.G., Stone S. Glucoreceptors controlling feeding and blood glucose: location in the hindbrain. Science 1981, 213:451-452.
49. Sandoval D.A., Bagnol D., Woods S.C., D'Alessio D.A., Seeley R.J. Arcuate glucagon-like peptide 1 receptors regulate glucose homeostasis but not food intake. Diabetes 2008, 57:2046-2054.
50. Shughrue P.J., Lane M.V., Merchenthaler I. Glucagon-like peptide-1 receptor (GLP1-R) mRNA in the rat hypothalamus. Endocrinology 1996, 137:5159-5162.
51. Talsania T., Anini Y., Siu S., Drucker D.J., Brubaker P.L. Peripheral exendin-4 and peptide YY(3-36) synergistically reduce food intake through different mechanisms in mice. Endocrinology 2005, 146:3748-3756.
52. Tang-Christensen M., Larsen P.J., Goke R., Fink-Jensen A., Jessop D.S., Moller M., Sheikh S.P. Central administration of GLP-1-(7-36) amide inhibits food and water intake in rats. Am. J. Physiol. 1996, 271:R848-R856.
53. Tauchi M., Zhang R., D'Alessio D.A., Stern J.E., Herman J.P. Distribution of glucagon-like peptide-1 immunoreactivity in the hypothalamic paraventricular and supraoptic nuclei. J. Chem. Neuroanat. 2008, 36:144-149.
54. Theodorakis M.J., Carlson O., Michopoulos S., Doyle M.E., Juhaszova M., Petraki K., Egan J.M. Human duodenal enteroendocrine cells: source of both incretin peptides, GLP-1 and GIP. Am. J. Physiol. Endocrinol. Metab. 2006, 290:E550-E559.
55. Thorens B. Expression cloning of the pancreatic beta cell receptor for the gluco-incretin hormone glucagon-like peptide 1. Proc. Natl Acad. Sci. USA 1992, 89:8641-8645.
56. Tolhurst G., Reimann F., Gribble F.M. Nutritional regulation of glucagon-like peptide-1 secretion. J. Physiol. 2009, 587:27-32.
57. Trapp S., Reimann F., Gribble F.M., Llewellyn-Smith I.J. Preproglucagon neurons project heavily to autonomic control regions of the CNS. Proc. Physiol. Soc. 2010, 18:C14.
58. Turton M.D., O'Shea D., Gunn I., Beak S.A., Edwards C.M., Meeran K., Choi S.J., Taylor G.M., Heath M.M., Lambert P.D., Wilding J.P., Smith D.M., Ghatei M.A., Herbert J., Bloom S.R. A role for glucagon-like peptide-1 in the central regulation of feeding. Nature 1996, 379:69-72.
59. Vahl T.P., Tauchi M., Durler T.S., Elfers E.E., Fernandes T.M., Bitner R.D., Ellis K.S., Woods S.C., Seeley R.J., Herman J.P., D'Alessio D.A. Glucagon-like peptide-1 (GLP-1) receptors expressed on nerve terminals in the portal vein mediate the effects of endogenous GLP-1 on glucose tolerance in rats. Endocrinology 2007, 148:4965-4973.
60. van Dijk G., Thiele T.E. Glucagon-like peptide-1 (7-36) amide: a central regulator of satiety and interoceptive stress. Neuropeptides 1999, 33:406-414.
61. Verdich C., Flint A., Gutzwiller J.P., Naslund E., Beglinger C., Hellstrom P.M., Long S.J., Morgan L.M., Holst J.J., Astrup A. A meta-analysis of the effect of glucagon-like peptide-1 (7-36) amide on ad libitum energy intake in humans. J. Clin. Endocrinol. Metab. 2001, 86:4382-4389.
62. Vrang N., Phifer C.B., Corkern M.M., Berthoud H.R. Gastric distension induces c-Fos in medullary GLP-1/2-containing neurons. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2003, 285:R470-R478.
63. Vrang N., Hansen M., Larsen P.J., Tang-Christensen M. Characterization of brainstem preproglucagon projections to the paraventricular and dorsomedial hypothalamic nuclei. Brain Res. 2007, 1149:118-126.
64. Wan S., Browning K.N., Travagli R.A. Glucagon-like peptide-1 modulates synaptic transmission to identified pancreas-projecting vagal motoneurons. Peptides 2007, 28:2184-2191.
65. Wan S., Coleman F.H., Travagli R.A. Glucagon-like peptide-1 excites pancreas-projecting preganglionic vagal motoneurons. Am. J. Physiol. Gastrointest. Liver Physiol. 2007, 292:G1474-G1482.
66. Wettergren A., Petersen H., Orskov C., Christiansen J., Sheikh S.P., Holst J.J. Glucagon-like peptide-1 7-36 amide and peptide YY from the L-cell of the ileal mucosa are potent inhibitors of vagally induced gastric acid secretion in man. Scand. J. Gastroenterol. 1994, 29:501-505.
67. Wettergren A., Wojdemann M., Holst J.J. Glucagon-like peptide-1 inhibits gastropancreatic function by inhibiting central parasympathetic outflow. Am. J. Physiol. 1998, 275:G984-G992.
68. Williams D.L., Baskin D.G., Schwartz M.W. Evidence that intestinal glucagon-like peptide-1 plays a physiological role in satiety. Endocrinology 2009, 150:1680-1687.
69. Yamamoto H., Lee C.E., Marcus J.N., Williams T.D., Overton J.M., Lopez M.E., Hollenberg A.N., Baggio L., Saper C.B., Drucker D.J., Elmquist J.K. Glucagon-like peptide-1 receptor stimulation increases blood pressure and heart rate and activates autonomic regulatory neurons. J. Clin. Invest. 2002, 110:43-52.
70. Yamamoto H., Kishi T., Lee C.E., Choi B.J., Fang H., Hollenberg A.N., Drucker D.J., Elmquist J.K. Glucagon-like peptide-1-responsive catecholamine neurons in the area postrema link peripheral glucagon-like peptide-1 with central autonomic control sites. J. Neurosci. 2003, 23:2939-2946.
71. Yettefti K., Orsini J.C., Perrin J. Characteristics of glycemia-sensitive neurons in the nucleus tractus solitarii: possible involvement in nutritional regulation. Physiol. Behav. 1997, 61:93-100.